Présentation: Stratégie de l'entreprise

AN EXPERT IN SENSORY ANALYSIS

DELIVERING FOODTECH SOLUTIONS AND PIONEERING MEDTECH SOLUTIONS,

READY TO SCALE

Copyright 2019 - Alpha MOS Confidential and Proprietary

Disclaimer

This presentation and all the information provided by Alpha MOS Group (orally or in writing) in connection to this presentation (collectively the "Presentation") has been prepared by Alpha MOS Group ("AM"), in connection with the potential investment in AM (the "Transaction") or in one of its affiliates ("AM Affiliates").

This Presentation shall be provided to a limited number of prospective investors (the "Recipients") who are or might be interested to participate in the Transaction. This Presentation is provided solely for information purposes.

By receiving and/or having access to this Presentation, each Recipient acknowledges and agrees to the following:

• •This Presentation is strictly confidential. The Recipients are not allowed to disclose or disseminate the Presentation to third parties, except to the Recipient's directors, officers and employees ("Recipient's Representatives") and solely for the purpose of evaluating the Transaction.

• •The Presentation has been prepared and is provided to the Recipients for the sole purpose of assisting the latter in the assessment of the Transaction and in making their own evaluation of AM. The Presentation does not intend to be exhaustive or to contain all the information that a prospective investor might require or consider useful in order to take a conscious decision about the Transaction.

• •The Presentation is provided without any warranty, express, implied or otherwise, regarding the Presentation's completeness, accuracy or performance In all cases, the Recipients should conduct their own verifications, investigations and analyses of AM, its business and operations, the Transaction and the data contained in this Presentation.

• •The information contained in the Presentation has been obtained from management forecasts and only reflects prevailing market conditions and AM views as of the present date, all of which are subject to change. AM's opinions and estimates constitute AM's judgment and should be regarded as indicative, preliminary and for illustrative purposes only. AM has relied in public sources and/or information provided to or reviewed by AM. In addition, the analysis is not and does not intend to be a formal assessment on the assets, stock, or business of AM or any other entity. Neither AM nor AM's directors, auditors, officers, employees, advisors (hereinafter "AM Representatives"), shall make any representation or warranty (expressed or implied) as to the accuracy, correctness or completeness of the Presentation, as well as on the reliability of the forecasts and assumptions, contained in this Presentation and/or in any other written or oral information supplied or otherwise made available to the Recipients in connection with this Presentation.

• •AM does not intend to provide any representations or warranties as to the achievement or the reasonableness of any future projections, forecasts, prospects, estimates or returns contained in this Presentation.

• •AM and their respective Representatives shall not be responsible for the use of the Presentation or the information arising from it by the Recipient, and/or by any of directors, officers or employees, or by any of the Recipient's subsidiaries or affiliates (collectively, the "Affiliates") and/or the use by any of the Recipient's Representatives of this Presentation or any other written or oral information supplied to, or anyhow obtained by, the Recipient or any of its Affiliates or Representatives in the course of their investigations and evaluation of AM.

• •AM hereby states that all returns shown in this Presentation are projected and not actual. AM does not guarantee these results. There is no assurance that these returns will be met. The projections are based upon the funding of the full investment amount by end December 2018. Revenues are based upon business strategy executing as planned.

• •AM does not assume any obligation to provide the Recipient with access to any additional information in connection with this Presentation, or to refrain from providing modified, additional or alternative information to other Recipients.

• •Nor AM, neither AM's Affiliates or AM's Representatives, shall be responsible for any costs or expenses incurred directly or indirectly by the Recipients as a result of the assessment, evaluation or investigation of AM and the Transaction and/or in the negotiations arising from the proposed Transaction.

• •The Recipient's use and reliance in the Presentation is at the sole risk of each Recipient. Recipients shall have no valid claim against AM, AM's Affiliates or AM's Representatives for the use or misuse of the Presentation by the Recipient or Recipient's Representatives.

• •If the Recipients decide to initiate any kind of negotiation or due diligence regarding to the Project, such Recipient shall enter into a Non-Disclosure Agreement ("NDA") with AM. Following the execution of the NDA, AM will conduct a legal analysis of the Recipient, pursuant to the legal obligations that arise from the fact that (i) AM shares are listed on Euronext Paris, Eurolist - Compartment C (FR0000062804 ALM); and that (ii) AM is a company subject to "Autorité des Marchés Financiers"supervision (French financial authorities).

Executive Summary: an expert in sensory analysis delivering FoodTech solutions and pioneering MedTech solutions, ready to scale

25 years experience in sensory analysis

Providing critical sensory analysis servicesbased onVolatile Organic Compound (VOC)

Bringinga new solution to complement human sensory panelscurrently used in analysis, a human intensive and costly process

Leadership position in the Food & beverage industryfor quality testing in product development with Top100 key accounts and a strategic partnership with Coca-Cola

25 years experienceand know how

Fablesssince 2018

With a strong technology edge

A unique expertise in VOC sensing and analysis

Ability to combine theright instrumentwith aproprietary software cumulating 25 years experienceto capture and analyze sensory characteristics inmultiple environments

Successfully validatedwith world-class F&B customers in the Product Development phase

Easy to usesolutions usable both in R&D centers and production sites

10 patent families granted

And a clear strategic roadmap to address fast growing segments and promising markets

FoodTech ($5bn market for product testing) Leveraging our validated platform and strong customer relations to expand beyond product development into quality control directly on production sites, enabling our clients' shift towards industry 4.0 New product design ready to scale Signing new key alliances and continue to invest in R&D à Growing market position focusing onTop100 Food & Beverage key accounts

MedTech ($10bn market for glucose monitoring devices) Miniaturizing our patented solution to build an economical and non-invasive breath analyzer platform to monitor chronic conditions, starting with diabetes. Promising early phase clinical study (>100 patients) and identification of breath VOC for diabetic test. Prototypes ready for demos with partners and customers à Fueling development towards FDA pre-submission and product development

2021 objectives

FoodTech

Revenue

>15M€

CAGR 2018-2021

>45%

EBITDA Margin

>15%

MedTech

Launching manufacturing with the right MedTechpartner in 2021

Volatile Organic Compounds (VOC) are critical indicators in sensory analysis

Most scents or odors are associated with VOC: organic chemicals that evaporate from the liquid or solid form of the compound and enter the surrounding air

In Food & Beverage, VOC can vary greatly in quantitydriving a significant impact on the final product's aroma and perceived quality

In the Medical sector, VOC can also be found in the exhaled breath of humans and area critical indicator of normal metabolic activity or pathological disorders

25 years of experience in VOC based sensory analysis solutions

Ready to scale up

We are an expert in VOC based sensory analysis solutions across multiple markets: food, beverage, medical,…

50 employees (March 1, 2019)

>95% international sales

1,000+ instruments installed globally

Fabless company

10 Patent families granted

Traded on EuroNext Paris